LivaNova PLC

LIVNNASDAQ · USD
76.63USD0.00 (+1.58%)
799

LivaNova PLC (LIVN) Implied Volatility Current

LIVN implied volatility is 44%. IV Rank is 35%, placing current premiums in the middle of their 52-week range.

Read more

Tracking LIVN implied volatility helps you identify when options premiums on LivaNova PLC are historically cheap or expensive, and where the best trades are hiding. LivaNova PLC implied volatility reflects the market's expectation of future price movement: when LIVN IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor LivaNova PLC's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For LIVN, tracking metrics like LIVN IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on LIVN signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea.

It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where LIVN implied volatility sits today versus where it has been. Our scanner ranks LivaNova PLC implied volatility against its historical range, surfaces extremes in LIVN IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether LivaNova PLC IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
34.52%IV Rank
Moderate

IV is below its typical range - premiums look reasonable for buyers.

Implied Volatility (30d)43.64%

IV Rank34.52%

Historical Volatility (30d)23.42%

IV - HV+20.22%

As of September 25, 2026

Trade options with IV on your side

Track LIVN IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial